Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > Regulatory & Safety

News in brief

Camlin Fine Chemicals’ board of directors OK Italian acquisition

24-Nov-2010

Related topics: Mergers and acquisitions, Regulatory & Safety, Excipients, raw materials and intermediates

Camlin Fine Chemicals has been given the green light from its board of directors to acquire an unnamed Italian fine chemicals manufacturer and form a subsidiary company to help boost its presence in the Middle East.

The Indian active pharmaceutical ingredient (API) maker told Bombay Stock Exchange (BSE) that during a meeting held on November 22, 2010, its board of directors approved a proposal to acquire the Italian firm through its wholly owned subsidiary to be set up in Mauritius.

In the meeting the board also approved formation of a subsidiary Company in the United Arab Emirates (UAE) which Camlin hopes will further establish its business through Middle Eastern regions.